136 related articles for article (PubMed ID: 34098886)
1. SOX14 hypermethylation as a tumour biomarker in cervical cancer.
Zhao J; Cao H; Zhang W; Fan Y; Shi S; Wang R
BMC Cancer; 2021 Jun; 21(1):675. PubMed ID: 34098886
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma.
Wang R; van Leeuwen RW; Boers A; Klip HG; de Meyer T; Steenbergen RD; van Criekinge W; van der Zee AG; Schuuring E; Wisman GB
Oncotarget; 2016 Dec; 7(49):80735-80750. PubMed ID: 27738327
[TBL] [Abstract][Full Text] [Related]
3. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.
Wu JH; Liang XA; Wu YM; Li FS; Dai YM
Oncol Rep; 2013 Jan; 29(1):125-32. PubMed ID: 23064448
[TBL] [Abstract][Full Text] [Related]
4. Real-time colorimetric detection of DNA methylation of the
Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
[TBL] [Abstract][Full Text] [Related]
5. The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer.
Zhang W; Cao H; Yang J; Zhao J; Liang Z; Kang X; Wang R
BMC Cancer; 2022 Jun; 22(1):636. PubMed ID: 35681118
[TBL] [Abstract][Full Text] [Related]
6. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
[TBL] [Abstract][Full Text] [Related]
7. Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer.
Kim HJ; Kim CY; Jin J; Bae MK; Kim YH; Ju W; Kim YH; Kim SC
Diagn Cytopathol; 2018 Jan; 46(1):15-21. PubMed ID: 29063719
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance.
Jiao X; Zhang S; Jiao J; Zhang T; Qu W; Muloye GM; Kong B; Zhang Q; Cui B
Clin Epigenetics; 2019 Aug; 11(1):120. PubMed ID: 31426855
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.
Verlaat W; Snoek BC; Heideman DAM; Wilting SM; Snijders PJF; Novianti PW; van Splunter AP; Peeters CFW; van Trommel NE; Massuger LFAG; Bekkers RLM; Melchers WJG; van Kemenade FJ; Berkhof J; van de Wiel MA; Meijer CJLM; Steenbergen RDM
Clin Cancer Res; 2018 Jul; 24(14):3456-3464. PubMed ID: 29632006
[No Abstract] [Full Text] [Related]
10. SOX14 activates the p53 signaling pathway and induces apoptosis in a cervical carcinoma cell line.
Stanisavljevic D; Petrovic I; Vukovic V; Schwirtlich M; Gredic M; Stevanovic M; Popovic J
PLoS One; 2017; 12(9):e0184686. PubMed ID: 28926586
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean population.
Brebi P; Maldonado L; Noordhuis MG; Ili C; Leal P; Garcia P; Brait M; Ribas J; Michailidi C; Perez J; Soudry E; Tapia O; Guzman P; Muñoz S; Van Neste L; Van Criekinge W; Irizarry R; Sidransky D; Roa JC; Guerrero-Preston R
Epigenetics; 2014 Feb; 9(2):308-17. PubMed ID: 24241165
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population.
Li N; Hu Y; Zhang X; Liu Y; He Y; van der Zee AGJ; Schuuring E; Wisman GBA
Int J Cancer; 2021 Apr; 148(7):1768-1777. PubMed ID: 33300604
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
14. Folate deficiency and FHIT hypermethylation and HPV 16 infection promote cervical cancerization.
Bai LX; Wang JT; Ding L; Jiang SW; Kang HJ; Gao CF; Chen X; Chen C; Zhou Q
Asian Pac J Cancer Prev; 2014; 15(21):9313-7. PubMed ID: 25422218
[TBL] [Abstract][Full Text] [Related]
15. Aberrant gene-specific DNA methylation signature analysis in cervical cancer.
Bhat S; Kabekkodu SP; Varghese VK; Chakrabarty S; Mallya SP; Rotti H; Pandey D; Kushtagi P; Satyamoorthy K
Tumour Biol; 2017 Mar; 39(3):1010428317694573. PubMed ID: 28351298
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of ZAR1 and SFRP4 methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase I.
Brebi P; Hoffstetter R; Andana A; Ili CG; Saavedra K; Viscarra T; Retamal J; Sanchez R; Roa JC
Biomarkers; 2014 May; 19(3):181-8. PubMed ID: 24787227
[TBL] [Abstract][Full Text] [Related]
17. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
Singh A; Gupta S; Badarukhiya JA; Sachan M
Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
[TBL] [Abstract][Full Text] [Related]
18. Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages.
Schmitz M; Eichelkraut K; Schmidt D; Zeiser I; Hilal Z; Tettenborn Z; Hansel A; Ikenberg H
BMC Cancer; 2018 Dec; 18(1):1197. PubMed ID: 30509219
[TBL] [Abstract][Full Text] [Related]
19. Combined clinical and genetic testing algorithm for cervical cancer diagnosis.
Liou YL; Zhang TL; Yan T; Yeh CT; Kang YN; Cao L; Wu N; Chang CF; Wang HJ; Yen C; Chu TY; Zhang Y; Zhang Y; Zhou H
Clin Epigenetics; 2016; 8():66. PubMed ID: 27293491
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer.
Kim MK; Lee IH; Lee KH; Lee YK; So KA; Hong SR; Hwang CS; Kee MK; Rhee JE; Kang C; Hur SY; Park JS; Kim TJ
J Gynecol Oncol; 2016 Mar; 27(2):e14. PubMed ID: 26768780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]